ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Xilio Therapeutics Inc

Xilio Therapeutics Inc (XLO)

9,665
0,395
( 4,26% )
Mis à jour : 18:04:19

Xilio Therapeutics Inc (XLO) Opérations d'Initiés

-
Filtrer par:
Date Nom du détenteur Actions transigées Fourchette de valeur ($) Type d'opération Fourchette de prix ($) Actions en fin de déclaration % de variation
2026-03-26Dr. James S. ShannonIndependent Director5,00k43,95kAchat8,7910,00k100,00%
2026-02-13Gilead Sciences, Inc.Société3,74M0,00Open Market Derivative Acquisition0,0040,38M10,20%
2026-01-01Dr. Rene RussoPresident, CEO & Director3,16k0,00Derivative Exercise and Retained Stock-23,24k15,74%
2026-01-01Mr. Kevin M. BrennanSVP of Finance & Accounting226,710,00Derivative Exercise and Retained Stock-455,0099,31%
2026-01-01Mr. Kevin M. BrennanSVP of Finance & Accounting-130,431,17kDerivative Exercise and Sale9,00455,00-
2026-01-01Mr. Christopher FrankenfieldCFO & COO881,790,00Derivative Exercise and Retained Stock-1,77k99,39%
2026-01-01Mr. Christopher FrankenfieldCFO & COO-502,144,52kDerivative Exercise and Sale9,001,77k-
2026-01-01Dr. Katarina LuptakovaInitié1,19k0,00Derivative Exercise and Retained Stock-2,38k100,00%
2025-11-21Mr. Christopher FrankenfieldCFO & COO-11,08k0,00Other Derivative Disposition21,0011,08k-50,00%

Dernières Valeurs Consultées

Delayed Upgrade Clock